Please login to the form below

Not currently logged in
Email:
Password:

Novo Nordisk names SVP biopharmaceuticals in US

Promotion for Eddie Williams
Novo Nordisk Eddie Williams

Novo Nordisk has promoted Eddie Williams to senior VP of biopharmaceuticals in the US.

Williams has been with Denmark-based diabetes specialist Novo since 2006, when he joined as corporate VP, biopharmaceuticals in the US, leading the sales and marketing, business development and new product commercialisation unit.

Prior to this role, he was a VP at Novartis in the US, holding responsibility for the sales, respiratory & dermatology business unit. He has also served in a senior sales role at Pharmacia.

Jesper Hoiland, president of Novo Nordisk Inc, the company's US affiliate, commented on the impact Williams has had on Novo's biopharma business in the US.

"That business has flourished under Eddie's experienced leadership,” said Hoiland. His promotion to senior vice president demonstrates the company's focus on, and commitment to, our pipeline of life-changing biological therapies."

4th February 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page

For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics